RMTI (Rockwell Medical) Cyclically Adjusted Revenue per Share: $96.61 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

RMTI Rockwell Medical Inc RMTI
26 GF Score
Price $6.38
GF Value $0.95
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Rockwell Medical Cyclically Adjusted Revenue per Share?

Rockwell Medical RMTI -0.16% 26 Cyclically Adjusted Revenue per Share is $96.61 as of Mar. 2026. GuruFocus rates RMTI with a GF Score™ of 26/100 and a GF Value™ of $0.95 (Significantly Overvalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Rockwell Medical's adjusted revenue per share for the three months ended in Mar. 2026 was $4.398. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is $96.61 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Rockwell Medical's average Cyclically Adjusted Revenue Growth Rate was -10.60% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was -10.80% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was -11.00% per year. During the past 10 years, the average Cyclically Adjusted Revenue Growth Rate was -11.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of Rockwell Medical was 10.90% per year. The lowest was -13.40% per year. And the median was -8.25% per year.

As of today (2026-07-22), Rockwell Medical's current stock price is $6.38. Rockwell Medical's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2026 was $96.61. Rockwell Medical's Cyclically Adjusted PS Ratio of today is 0.07.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Rockwell Medical was 0.33. The lowest was 0.01. And the median was 0.09.


Rockwell Medical  (NAS:RMTI) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Rockwell Medical's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=6.38/96.61
=0.07

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Rockwell Medical was 0.33. The lowest was 0.01. And the median was 0.09.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Rockwell Medical Cyclically Adjusted Revenue per Share Related Terms


Rockwell Medical Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for Rockwell Medical's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rockwell Medical Cyclically Adjusted Revenue per Share Chart

Rockwell Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 157.55 138.66 122.68 110.23 98.40

Rockwell Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 108.09 105.64 102.53 98.40 96.61

RMTI vs CPHI, TXMD, MRMD: Cyclically Adjusted Revenue per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Rockwell Medical's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Rockwell Medical Cyclically Adjusted PS Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Rockwell Medical's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Rockwell Medical's Cyclically Adjusted PS Ratio falls into.


RMTI
26GF Score
Rockwell Medical Inc RMTI
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rockwell Medical Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Rockwell Medical's adjusted Revenue per Share data for the three months ended in Mar. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=4.398/330.2130*330.2130
=4.398

Current CPI (Mar. 2026) = 330.2130.

Rockwell Medical Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201606 29.182 241.018 39.982
201609 27.798 241.428 38.021
201612 28.858 241.432 39.470
201703 31.653 243.801 42.872
201706 28.541 244.955 38.475
201709 31.388 246.819 41.993
201712 31.841 246.524 42.650
201803 32.079 249.554 42.447
201806 32.002 251.989 41.936
201809 35.777 252.439 46.800
201812 32.287 251.233 42.437
201903 29.979 254.202 38.943
201906 28.064 256.143 36.179
201909 26.564 256.759 34.163
201912 26.435 256.974 33.969
202003 25.826 258.115 33.040
202006 25.192 257.797 32.269
202009 23.400 260.280 29.687
202012 17.798 260.474 22.563
202103 18.182 264.877 22.667
202106 17.766 271.696 21.592
202109 18.743 274.310 22.563
202112 17.953 278.802 21.264
202203 18.881 287.504 21.686
202206 16.119 296.311 17.963
202209 10.125 296.808 11.265
202212 10.434 296.797 11.609
202303 10.712 301.836 11.719
202306 9.773 305.109 10.577
202309 8.638 307.789 9.267
202312 7.695 306.746 8.284
202403 7.731 312.332 8.174
202406 8.065 314.175 8.477
202409 8.734 315.301 9.147
202412 7.499 315.605 7.846
202503 5.545 319.799 5.726
202506 4.684 322.561 4.795
202509 4.422 324.800 4.496
202512 4.652 324.054 4.740
202603 4.398 330.213 4.398

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of $96.61 mean?
Rockwell Medical (RMTI) has a Cyclically Adjusted Revenue per Share of $96.61 as of Mar. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Rockwell Medical and its competitors.
Is Rockwell Medical's Cyclically Adjusted Revenue per Share too high?
Rockwell Medical's current Cyclically Adjusted Revenue per Share is $96.61. Overall, Rockwell Medical has a GF Score™ of 26/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rockwell Medical's Cyclically Adjusted Revenue per Share compare to CPHI and TXMD?
Rockwell Medical's Cyclically Adjusted Revenue per Share of $96.61 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Revenue per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on Rockwell Medical and its competitors. Rockwell Medical's current Cyclically Adjusted Revenue per Share is $96.61. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rockwell Medical stock overvalued right now?
Based on GuruFocus' analysis, Rockwell Medical (RMTI) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.95, compared to a current price of $6.38 — trading 571.6% above its estimated fair value. The current Cyclically Adjusted Revenue per Share is $96.61. Rockwell Medical's overall GF Score™ is 26/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For Rockwell Medical (RMTI), the current Cyclically Adjusted Revenue per Share is $96.61 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rockwell Medical (RMTI) Overvalued in 2026?

Based on GuruFocus' analysis, Rockwell Medical stock appears to be overvalued. The current stock price of $6.38 is trading 571.6% above its estimated GF Value™ of $0.95. GuruFocus considers Rockwell Medical to be Significantly Overvalued.

Key valuation signals for RMTI:

  • Cyclically Adjusted Revenue per Share: $96.61
  • GF Value™: $0.95 vs. price of $6.38 (571.6% above fair value)
  • GF Score™: 26/100 with 3 warning signs

No single metric tells the full story. See the RMTI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Rockwell Medical Business Description

Other Exchanges RWMA:Germany
Address 30142 South Wixom Road, Wixom, MI, USA, 48393
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.
26GF Score

Get the complete analysis for RMTI

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$6.38
Price
$0.95
GF Value